Bristol Myers Squibb Drug Patent Portfolio

Bristol Myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb News

Pharmalittle: Promising pancreatic cancer findings, Replimune medication not approved - STAT News

13 Apr, 2026

Bristol Myers Squibb's stock (US1101221083): Does its cancer treatment pipeline have the potential to drive growth?

10 Apr, 2026

Could Positive Camzyos Results Enhance BMY's Cardiovascular Offerings? - Yahoo Finance

30 Mar, 2026

Could the Recent Label Expansion of BMY's Opdivo Enhance Its Immuno-Oncology Portfolio? - TradingView

25 Mar, 2026

See More